Ralliant Corp Dossier
Qualitative Analysis
Business overview
Ralliant Corp (NYSE: RAL) is a premier global technology company specializing in the design, development, manufacture, sale, and service of precision instruments and highly engineered products. Spun off from Fortive Corporation on June 28, 2025, Ralliant operates through two primary strategic segments: Test and Measurement (T&M), and Sensors and Safety Systems (S&SS). The company serves mission-critical applications across high-growth vectors including semiconductors, utilities, defense and space, and power electronics. Its operations are underpinned by the Ralliant Business System (RBS), a comprehensive set of lean operational, innovation, and leadership tools derived from the Danaher Business System.
Research as of 19 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
An enterprise-wide productivity initiative overseen directly by the CEO office to optimize cost structures, simplify the organization, and drive margin expansion.
Expected impact: Expected to deliver $50 million to $60 million in annualized run-rate savings by 2028, contributing to approximately 50% total incremental adjusted EBITDA margins through 2028.
Scaling up production capabilities of the universal Arm Fire Device (AFD), a critical safety component in solid rocket motor (SRM) applications, at the Pacific Scientific Energetic Materials Company (PacSci EMC) operating unit.
Expected impact: Expands SRM production capacity, modernizes manufacturing processes, and reduces lead times to address critical defense supply chain shortfalls.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Recent Acquisitions
To bolster Ralliant's innovative portfolio of products and services for engineers with complementary test and measurement solutions enabling the global energy transition.
Financial impact: The acquisition initially added approximately $1.18 billion of goodwill to the Test & Measurement segment. The subsequent $1.4 billion impairment charge significantly impacted GAAP net earnings for fiscal year 2025.